Literature DB >> 11827484

Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.

Pierre Nioche1, Wang-Qing Liu, Isabelle Broutin, Franck Charbonnier, Marie-Thérèse Latreille, Michel Vidal, Bernard Roques, Christiane Garbay, Arnaud Ducruix.   

Abstract

The activation of growth factor receptors induces phosphorylation of tyrosine residues in its C-terminal part, creating binding sites for SH2 domain-containing proteins. Grb2 is a protein that recruits Sos, the exchange factor for Ras. Recruitment of Sos allows for Ras activation and subsequent signal transmission. This promotes translocation of MAP kinases into the nucleus and activation of early transcription factors. Grb2, a 25 kDa protein, is composed of one SH2 domain surrounded by two SH3 domains. The SH2 domain of Grb2 binds to class II phosphotyrosyl peptides with the consensus sequence pYXNX. Thus, Grb2 is a good example of a bifunctional adaptor protein that brings proteins into close proximity, allowing signal transduction through proteins located in different compartments. To explore the interactions between Grb2 and phosphorylated ligands, we have solved the crystal structure of complexes between the Grb2-SH2 domain and peptides corresponding to Shc-derived sequences. Two structures are described: the Grb2-SH2 domain in complex with PSpYVNVQN at 1.5 A; and the Grb2-SH2 domain in complex with mAZ*-pY-(alphaMe)pY-N-NH2 pseudo-peptide, at 2 A. Both are compared to an unliganded SH2 structure determined at 2.7 A which, interestingly enough, forms a dimer through two swapping subdomains from two symmetry-related molecules. The nanomolar affinity of the mAZ-pY-(alphaMe)pY-N-NH2 pseudo-peptide for Grb2-SH2 is related to new interactions with non- conserved residues. The design of Grb2-SH2 domain inhibitors that prevent interaction with tyrosine kinase proteins or other adaptors like Shc or IRS1 should provide a means to interrupt the Ras signaling pathway. Newly synthesized pseudo-peptides exhibit nanomolar affinities for the Grb2-SH2 domain. It will then be possible to design new inhibitors with similar affinity and simpler chemical structures. Copyright 2002 Elsevier Science Limited.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11827484     DOI: 10.1006/jmbi.2001.5299

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  32 in total

1.  MMDB: Entrez's 3D-structure database.

Authors:  Jie Chen; John B Anderson; Carol DeWeese-Scott; Natalie D Fedorova; Lewis Y Geer; Siqian He; David I Hurwitz; John D Jackson; Aviva R Jacobs; Christopher J Lanczycki; Cynthia A Liebert; Chunlei Liu; Thomas Madej; Aron Marchler-Bauer; Gabriele H Marchler; Raja Mazumder; Anastasia N Nikolskaya; Bachoti S Rao; Anna R Panchenko; Benjamin A Shoemaker; Vahan Simonyan; James S Song; Paul A Thiessen; Sona Vasudevan; Yanli Wang; Roxanne A Yamashita; Jodie J Yin; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2003-01-01       Impact factor: 16.971

2.  Loops govern SH2 domain specificity by controlling access to binding pockets.

Authors:  Tomonori Kaneko; Haiming Huang; Bing Zhao; Lei Li; Huadong Liu; Courtney K Voss; Chenggang Wu; Martin R Schiller; Shawn Shun-Cheng Li
Journal:  Sci Signal       Date:  2010-05-04       Impact factor: 8.192

Review 3.  The intertwining of structure and function: proposed helix-swapping of the SH2 domain of Grb7, a regulatory protein implicated in cancer progression and inflammation.

Authors:  Sally Pias; Tabitha A Peterson; Dennis L Johnson; Barbara A Lyons
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

4.  Protein-ligand interactions: probing the energetics of a putative cation-π interaction.

Authors:  James M Myslinski; John H Clements; Stephen F Martin
Journal:  Bioorg Med Chem Lett       Date:  2014-05-09       Impact factor: 2.823

5.  Natural Products and Their Mimics as Targets of Opportunity for Discovery.

Authors:  Stephen F Martin
Journal:  J Org Chem       Date:  2017-09-15       Impact factor: 4.354

6.  In vitro phosphorylation of the focal adhesion targeting domain of focal adhesion kinase by Src kinase.

Authors:  Jennifer Cable; Kirk Prutzman; Harsha P Gunawardena; Michael D Schaller; Xian Chen; Sharon L Campbell
Journal:  Biochemistry       Date:  2012-03-08       Impact factor: 3.162

7.  Dimerization in the Grb7 protein.

Authors:  Tabitha A Peterson; Renee L Benallie; Andrew M Bradford; Sally C Pias; Jaron Yazzie; Siamee N Lor; Zachary M Haulsee; Chad K Park; Dennis L Johnson; Larry R Rohrschneider; Anne Spuches; Barbara A Lyons
Journal:  J Mol Recognit       Date:  2012-08       Impact factor: 2.137

8.  An NMR strategy for fragment-based ligand screening utilizing a paramagnetic lanthanide probe.

Authors:  Tomohide Saio; Kenji Ogura; Kazumi Shimizu; Masashi Yokochi; Terrence R Burke; Fuyuhiko Inagaki
Journal:  J Biomol NMR       Date:  2011-09-17       Impact factor: 2.835

9.  Solution structure of the human Grb7-SH2 domain/erbB2 peptide complex and structural basis for Grb7 binding to ErbB2.

Authors:  Monika Ivancic; Roger J Daly; Barbara A Lyons
Journal:  J Biomol NMR       Date:  2003-11       Impact factor: 2.835

10.  Binding specificity of SH2 domains: insight from free energy simulations.

Authors:  Wenxun Gan; Benoît Roux
Journal:  Proteins       Date:  2009-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.